Zicam Products
Allegations: Falsely advertising that products are “clinically proven to shorten colds” when there is no scientific evidence to support such claims
In December 2015, a class-action lawsuit was filed against Zicam for allegedly deceptively marketing Zicam Pre-Cold Medicine products – including RapidMelts, Oral Mist, Ultra Crystals, Lozenges, and Chewables – as having the ability to treat cold symptoms without adequate evidence to support such claims and when scientific evidence shows that the products are “nothing more than a placebo.” (Gulkis et al v. Zicam LLC and Matrixx Initiatives, Inc., Case No. 15-cv-9843, S. D. NY.)
For more information about other class-action lawsuits regarding products claiming to treat cold symptoms and TINA.org’s coverage of them, click here.
Allegations: Falsely advertising that products are “clinically proven to shorten colds” when there is no scientific evidence to support such claims
May 2019: The appeal was dismissed for failure to prosecute because the objector did not pay the filing fees. December 2018: An objector filed a Notice of Appeal regarding the…
FTC says civil penalty against Williams-Sonoma is “the largest ever in a Made in USA case.”
The NBA superstar isn’t just cashing endorsement checks.
Lawsuit alleges environmental claims don’t stick.
Got milk? Apparently not.
Flag on the play.